Cargando…

Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications

Although mucopolysaccharidoses (MPS) are caused by mutations in genes coding for enzymes responsible for degradation of glycosaminoglycans, storage of these compounds is crucial but is not the only pathomechanism of these severe, inherited metabolic diseases. Among various factors and processes infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pierzynowska, Karolina, Gaffke, Lidia, Cyske, Zuzanna, Węgrzyn, Grzegorz, Buttari, Brigitta, Profumo, Elisabetta, Saso, Luciano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468662/ https://www.ncbi.nlm.nih.gov/pubmed/34577086 http://dx.doi.org/10.3390/molecules26185616

Ejemplares similares

Complex Changes in the Efficiency of the Expression of Many Genes in Monogenic Diseases, Mucopolysaccharidoses, May Arise from Significant Disturbances in the Levels of Factors Involved in the Gene Expression Regulation Processes
por: Cyske, Zuzanna, et al.
Publicado: (2022)

Gene Expression-Related Changes in Morphologies of Organelles and Cellular Component Organization in Mucopolysaccharidoses
por: Gaffke, Lidia, et al.
Publicado: (2021)

Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach
por: Żabińska, Magdalena, et al.
Publicado: (2023)

Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses
por: Rintz, Estera, et al.
Publicado: (2020)

Tubulin Cytoskeleton in Neurodegenerative Diseases–not Only Primary Tubulinopathies
por: Cyske, Zuzanna, et al.
Publicado: (2022)

Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies
por: Pierzynowska, Karolina, et al.
Publicado: (2020)

Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients
por: Pierzynowska, Karolina, et al.
Publicado: (2019)

Expression of Long Noncoding RNAs in Fibroblasts from Mucopolysaccharidosis Patients
por: Cyske, Zuzanna, et al.
Publicado: (2023)

Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach
por: Pierzynowska, Karolina, et al.
Publicado: (2023)

Enrofloxacin—The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?
por: Grabowski, Łukasz, et al.
Publicado: (2022)

Changes in expressions of genes involved in the regulation of cellular processes in mucopolysaccharidoses as assessed by fibroblast culture-based transcriptomic analyses
por: Gaffke, Lidia, et al.
Publicado: (2020)

Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach
por: Cyske, Zuzanna, et al.
Publicado: (2022)

Activities of (Poly)phenolic Antioxidants and Other Natural Autophagy Modulators in the Treatment of Sanfilippo Disease: Remarkable Efficacy of Resveratrol in Cellular and Animal Models
por: Rintz, Estera, et al.
Publicado: (2022)

Roles of the Oxytocin Receptor (OXTR) in Human Diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2023)

Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses
por: Baydakova, Galina, et al.
Publicado: (2020)

Proteasome Composition and Activity Changes in Cultured Fibroblasts Derived From Mucopolysaccharidoses Patients and Their Modulation by Genistein
por: Pierzynowska, Karolina, et al.
Publicado: (2020)

Editorial: Molecular Aspects of Mucopolysaccharidoses
por: Węgrzyn, Grzegorz, et al.
Publicado: (2022)

Impaired ion homeostasis as a possible associate factor in mucopolysaccharidosis pathogenesis: transcriptomic, cellular and animal studies
por: Gaffke, Lidia, et al.
Publicado: (2021)

Underestimated Aspect of Mucopolysaccharidosis Pathogenesis: Global Changes in Cellular Processes Revealed by Transcriptomic Studies
por: Gaffke, Lidia, et al.
Publicado: (2020)

Differential Chromosome- and Plasmid-Borne Resistance of Escherichia coli hfq Mutants to High Concentrations of Various Antibiotics
por: Gaffke, Lidia, et al.
Publicado: (2021)

Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2018)

Ferroptosis and Its Modulation by Autophagy in Light of the Pathogenesis of Lysosomal Storage Diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2021)

Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway
por: Ucar, Bercis Imge, et al.
Publicado: (2021)

How close are we to therapies for Sanfilippo disease?
por: Gaffke, Lidia, et al.
Publicado: (2017)

Transcriptomic Approaches in Studies on and Applications of Chimeric Antigen Receptor T Cells
por: Pierzynowska, Karolina, et al.
Publicado: (2023)

Oxidative Stress in Cardiovascular Inflammation: Its Involvement in Autoimmune Responses
por: Profumo, Elisabetta, et al.
Publicado: (2011)

Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway
por: Sorice, Maurizio, et al.
Publicado: (2023)

An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
por: Saha, Sarmistha, et al.
Publicado: (2020)

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
por: Suzen, Sibel, et al.
Publicado: (2022)

Enhanced Efficiency of the Basal and Induced Apoptosis Process in Mucopolysaccharidosis IVA and IVB Human Fibroblasts
por: Brokowska, Joanna, et al.
Publicado: (2023)

Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment
por: Gaffke, Lidia, et al.
Publicado: (2023)

Mucopolysaccharidosis and Autophagy: Controversies on the Contribution of the Process to the Pathogenesis and Possible Therapeutic Applications
por: Pierzynowska, Karolina, et al.
Publicado: (2019)

The Nrf2 Pathway in Ischemic Stroke: A Review
por: Farina, Marcelo, et al.
Publicado: (2021)

An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects
por: Egbujor, Melford Chuka, et al.
Publicado: (2022)

T Lymphocyte Autoreactivity in Inflammatory Mechanisms Regulating Atherosclerosis
por: Profumo, Elisabetta, et al.
Publicado: (2012)

A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
por: Saha, Sarmistha, et al.
Publicado: (2022)

Regulatory Role of Nrf2 Signaling Pathway in Wound Healing Process
por: Süntar, Ipek, et al.
Publicado: (2021)

Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6/1 mouse model with prospects for early diagnosis and monitoring of the disease
por: Podlacha, Magdalena, et al.
Publicado: (2022)

Lupeol Counteracts the Proinflammatory Signalling Triggered in Macrophages by 7-Keto-Cholesterol: New Perspectives in the Therapy of Atherosclerosis
por: Saha, Sarmistha, et al.
Publicado: (2020)

Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
por: Gall Trošelj, Koraljka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_60mhdvum8rmeg7foq9ea77fv0t